|
EP1877557A2
(en)
|
2005-04-04 |
2008-01-16 |
The Board of Regents of The University of Texas System |
Micro-rna's that regulate muscle cells
|
|
CA2609142C
(en)
|
2005-05-27 |
2016-02-09 |
Fondazione Centro San Raffaele Del Monte Tabor |
Therapeutic gene vectors comprising mirna target sequences
|
|
WO2006128245A1
(en)
*
|
2005-06-03 |
2006-12-07 |
Southern Adelaide Health Service-Flinders Medical Centre |
Targeting cells with altered microrna expression
|
|
AU2007281261B2
(en)
|
2006-08-01 |
2013-03-21 |
Board Of Regents Of The University Of Texas System |
Identification of a micro-RNA that activates expression of beta-myosin heavy chain
|
|
WO2008071959A1
(en)
*
|
2006-12-12 |
2008-06-19 |
Oxford Biomedica (Uk) Limited |
Lentiviral vectors comprising micrornas
|
|
US20100111873A1
(en)
*
|
2007-02-20 |
2010-05-06 |
Russell Stephen J |
Treating cancer with viral nucleic acid
|
|
EP2187896B1
(en)
|
2007-07-31 |
2016-01-13 |
The Board of Regents of The University of Texas System |
Inhibitors of mir-499 and mir-208b for use in the treatment of pathologic cardiac hypertrophy, heart failure or myocardial infarction
|
|
EP2182969B1
(en)
|
2007-07-31 |
2016-11-16 |
The Board of Regents of The University of Texas System |
A micro-rna family that modulates fibrosis and uses thereof
|
|
KR20100099158A
(ko)
|
2007-11-09 |
2010-09-10 |
보드 오브 리전츠 더 유니버시티 오브 텍사스 시스템 |
심근세포 생존과 심장 회복을 제어하는 ＭＩＲ-15 집단의 마이크로ＲＮＡｓ
|
|
EP2265291B1
(en)
|
2008-03-17 |
2016-10-19 |
The Board of Regents of The University of Texas System |
Identification of micro-rnas involved in neuromuscular synapse maintenance and regeneration
|
|
CN102099472A
(zh)
*
|
2008-05-19 |
2011-06-15 |
新加坡科技研究局 |
使基因表达靶向于神经胶质瘤的核酸分子和方法
|
|
US9217155B2
(en)
|
2008-05-28 |
2015-12-22 |
University Of Massachusetts |
Isolation of novel AAV'S and uses thereof
|
|
US20100183558A1
(en)
|
2008-10-17 |
2010-07-22 |
Zhennan Lai |
Safe lentiviral vectors for targeted delivery of multiple therapeutic molecules
|
|
EP2364362B1
(en)
|
2008-11-12 |
2015-10-21 |
Ospedale San Raffaele S.r.l. |
Gene vector for inducing transgene-specific immune tolerance
|
|
CN101787373B
(zh)
*
|
2009-01-23 |
2013-06-19 |
中国人民解放军第二军医大学东方肝胆外科医院 |
一种携带外源基因在包装细胞中高效生产的重组病毒载体、其构建方法及其用途
|
|
RU2515926C2
(ru)
|
2009-02-04 |
2014-05-20 |
Борд Оф Риджентс, Дзе Юниверсити Оф Техас Систем |
Двойное нацеливание нп mir-208 и mir 499 в лечении заболеваний сердца
|
|
WO2010126370A2
(en)
|
2009-04-29 |
2010-11-04 |
Academisch Medisch Centrum Bij De Universiteit Van Amsterdam |
Means and methods for counteracting, preventing and/or determining heart failure, or a risk of heart failure
|
|
PL2424571T3
(pl)
*
|
2009-04-30 |
2020-10-19 |
Ospedale San Raffaele S.R.L |
Wektor genowy
|
|
WO2010127166A2
(en)
*
|
2009-04-30 |
2010-11-04 |
The Regents Of The University Of California |
Combination anti-hiv vectors, targeting vectors, and methods of use
|
|
US8734809B2
(en)
|
2009-05-28 |
2014-05-27 |
University Of Massachusetts |
AAV's and uses thereof
|
|
CA2769670C
(en)
*
|
2009-07-31 |
2018-10-02 |
Ethris Gmbh |
Rna with a combination of unmodified and modified nucleotides for protein expression
|
|
DE102009050308A1
(de)
|
2009-10-22 |
2011-05-05 |
Ludwig-Maximilians-Universität München |
RNA mit einer Kombination aus unmodifizierten und modifizierten Nucleotiden zur Proteinexpression
|
|
US8518392B2
(en)
|
2009-08-14 |
2013-08-27 |
Regeneron Pharmaceuticals, Inc. |
Promoter-regulated differentiation-dependent self-deleting cassette
|
|
WO2011130749A2
(en)
*
|
2010-04-16 |
2011-10-20 |
University Of Pittsburgh - Of The Commonwealth System Of Higher Education |
Identification of mutations in herpes simplex virus envelope glycoproteins that enable or enhance vector retargeting to novel non-hsv receptors
|
|
EP2561073B1
(en)
|
2010-04-23 |
2016-08-24 |
University of Massachusetts |
Cns targeting aav vectors and methods of use thereof
|
|
US9546369B2
(en)
|
2010-04-23 |
2017-01-17 |
University Of Massachusetts |
Multicistronic expression constructs
|
|
EP3444346B1
(en)
|
2010-04-23 |
2022-07-27 |
University of Massachusetts |
Aav-based treatment of cholesterol-related disorders
|
|
CN103189511B
(zh)
*
|
2010-07-12 |
2016-10-12 |
国立大学法人鸟取大学 |
利用siRNA导入的新型hiPSC制作法
|
|
EP2605798A1
(en)
|
2010-07-12 |
2013-06-26 |
Universidad Autònoma de Barcelona |
Gene therapy composition for use in diabetes treatment
|
|
US9248144B2
(en)
|
2010-11-11 |
2016-02-02 |
University Of Miami |
Compositions, kits and methods for treatment of cardiovascular, immunological and inflammatory diseases
|
|
KR20140004646A
(ko)
|
2010-12-15 |
2014-01-13 |
미라젠 세러퓨틱스 |
잠금 뉴클레오티드를 포함하는 마이크로rna 억제제
|
|
WO2012143401A1
(en)
|
2011-04-18 |
2012-10-26 |
INSERM (Institut National de la Santé et de la Recherche Médicale) |
Tissue-specific regulation of transgene expression
|
|
EP3318635A1
(en)
|
2011-04-21 |
2018-05-09 |
University of Massachusetts |
Raav-based compositions and methods for treating alpha-1 anti-trypsin deficiencies
|
|
CN107115352B
(zh)
|
2011-08-04 |
2020-10-30 |
耶达研究及发展有限公司 |
微rna和包含微rna的组合物
|
|
HUE047278T2
(hu)
|
2011-08-05 |
2020-04-28 |
Regeneron Pharma |
Humanizált univerzális könnyûláncú egerek
|
|
US9481895B2
(en)
|
2011-09-23 |
2016-11-01 |
Ge Healthcare Dharmacon, Inc. |
Introduction of modular vector elements during production of a lentivirus
|
|
KR20140091688A
(ko)
|
2011-10-06 |
2014-07-22 |
미라젠 세러퓨틱스 인코포레이티드 |
마이크로rna 조절에 의한 전신 에너지 항상성의 제어
|
|
EP2584040A1
(en)
|
2011-10-17 |
2013-04-24 |
Pharmahungary 2000 Kft. |
Compounds for treatment of ischemic injury
|
|
WO2013151665A2
(en)
|
2012-04-02 |
2013-10-10 |
modeRNA Therapeutics |
Modified polynucleotides for the production of proteins associated with human disease
|
|
US10501513B2
(en)
|
2012-04-02 |
2019-12-10 |
Modernatx, Inc. |
Modified polynucleotides for the production of oncology-related proteins and peptides
|
|
US9254311B2
(en)
|
2012-04-02 |
2016-02-09 |
Moderna Therapeutics, Inc. |
Modified polynucleotides for the production of proteins
|
|
US20150190532A1
(en)
|
2012-04-04 |
2015-07-09 |
The Trustees Of Columbia University In The City Of New York |
Smooth muscle specific inhibition for anti-restenotic therapy
|
|
CN107236735B
(zh)
|
2012-06-21 |
2019-11-08 |
米拉根医疗股份有限公司 |
包含锁核酸基序的基于寡核苷酸的抑制剂
|
|
CN103505743A
(zh)
*
|
2012-06-21 |
2014-01-15 |
北京命码生科科技有限公司 |
含功能性microRNA/siRNA的细胞微粒子及其应用
|
|
US9163235B2
(en)
|
2012-06-21 |
2015-10-20 |
MiRagen Therapeutics, Inc. |
Inhibitors of the miR-15 family of micro-RNAs
|
|
PL2922554T3
(pl)
*
|
2012-11-26 |
2022-06-20 |
Modernatx, Inc. |
Na zmodyfikowany na końcach
|
|
AU2013374345A1
(en)
*
|
2013-01-17 |
2015-08-06 |
Moderna Therapeutics, Inc. |
Signal-sensor polynucleotides for the alteration of cellular phenotypes
|
|
WO2014127215A1
(en)
|
2013-02-15 |
2014-08-21 |
Biogen Idec Ma Inc. |
Optimized factor viii gene
|
|
BR112016009465A8
(pt)
|
2013-10-28 |
2018-01-30 |
Univ Pittsburgh Commonwealth Sys Higher Education |
vetor de hsv oncolítico.
|
|
US20150147774A1
(en)
*
|
2013-11-22 |
2015-05-28 |
National University Of Singapore |
Expression construct for yeast and a method of using the construct
|
|
US10072251B2
(en)
|
2014-02-19 |
2018-09-11 |
University Of Massachusetts |
Recombinant AAVS having useful transcytosis properties
|
|
CA2942515C
(en)
|
2014-03-18 |
2025-12-09 |
University Of Massachusetts |
Raav-based compositions and methods for treating amyotrophic lateral sclerosis
|
|
WO2015164786A1
(en)
*
|
2014-04-25 |
2015-10-29 |
University Of Massachusetts |
Recombinant aav vectors useful for reducing immunity against transgene products
|
|
US11008561B2
(en)
|
2014-06-30 |
2021-05-18 |
Bioverativ Therapeutics Inc. |
Optimized factor IX gene
|
|
EP3194430A1
(en)
|
2014-09-16 |
2017-07-26 |
Universitat Autònoma De Barcelona |
Adeno-associated viral vectors for the gene therapy of metabolic diseases
|
|
US10370432B2
(en)
|
2014-10-03 |
2019-08-06 |
University Of Massachusetts |
Heterologous targeting peptide grafted AAVS
|
|
CN107073051B
(zh)
|
2014-10-21 |
2021-08-24 |
马萨诸塞大学 |
重组aav变体及其用途
|
|
US11085055B2
(en)
|
2014-12-05 |
2021-08-10 |
Universitat Autonoma De Barcelona |
Viral vectors for the treatment of diabetes
|
|
EP3247716A4
(en)
|
2015-01-20 |
2018-10-17 |
Miragen Therapeutics, Inc. |
Mir-92 inhibitors and uses thereof
|
|
EP3256170B1
(en)
|
2015-02-13 |
2020-09-23 |
University of Massachusetts |
Compositions and methods for transient delivery of nucleases
|
|
US11046955B2
(en)
|
2015-04-24 |
2021-06-29 |
University Of Massachusetts |
Modified AAV constructs and uses thereof
|
|
EP3319631A4
(en)
|
2015-07-08 |
2019-01-09 |
American Gene Technologies International Inc. |
HIV PREMUNICATION AND IMMUNOTHERAPY
|
|
EP3359670B2
(en)
|
2015-10-05 |
2024-02-14 |
ModernaTX, Inc. |
Methods for therapeutic administration of messenger ribonucleic acid drugs
|
|
AU2016341309A1
(en)
|
2015-10-22 |
2018-06-07 |
Modernatx, Inc. |
Cancer vaccines
|
|
US10188750B1
(en)
|
2015-10-23 |
2019-01-29 |
University Of South Florida |
Self-replicating cell selective gene delivery compositions, methods, and uses thereof
|
|
US10137144B2
(en)
|
2016-01-15 |
2018-11-27 |
American Gene Technologies International Inc. |
Methods and compositions for the activation of gamma-delta T-cells
|
|
CN116064678A
(zh)
|
2016-01-15 |
2023-05-05 |
美国基因技术国际有限公司 |
用于活化γ-δT细胞的方法和组合物
|
|
KR20180136435A
(ko)
|
2016-01-27 |
2018-12-24 |
온코루스, 인크. |
종양 살상형 바이러스 벡터 및 그의 용도
|
|
CA3012695A1
(en)
|
2016-02-01 |
2017-08-10 |
Bioverativ Therapeutics Inc. |
Optimized factor viii genes
|
|
WO2017139065A1
(en)
|
2016-02-08 |
2017-08-17 |
American Gene Technologies International Inc. |
Hiv vaccination and immunotherapy
|
|
CA3012344A1
(en)
|
2016-02-12 |
2017-08-17 |
University Of Massachusetts |
Anti-angiogenic mirna therapeutics for inhibiting corneal neovascularization
|
|
WO2017156311A2
(en)
|
2016-03-09 |
2017-09-14 |
American Gene Technologies International Inc. |
Combination vectors and methods for treating cancer
|
|
RS60410B1
(sr)
*
|
2016-04-08 |
2020-07-31 |
Krystal Biotech Inc |
Kompozicije za upotrebu u metodama za tretman rana, poremećaja i bolesti kože
|
|
WO2017201342A1
(en)
*
|
2016-05-18 |
2017-11-23 |
Modernatx, Inc. |
Polynucleotides encoding jagged1 for the treatment of alagille syndrome
|
|
EP3468617A4
(en)
|
2016-06-08 |
2020-01-22 |
American Gene Technologies International Inc. |
SYSTEM FOR THE NON-INTEGRAL VIRAL ISSUE AND PROCEDURE RELATING TO IT
|
|
AU2017290828A1
(en)
|
2016-06-30 |
2019-01-24 |
Virogin Biotech Canada Ltd |
Pseudotyped oncolytic viral delivery of therapeutic polypeptides
|
|
AU2017292582C1
(en)
|
2016-07-08 |
2021-11-11 |
American Gene Technologies International Inc. |
HIV pre-immunization and immunotherapy
|
|
GB201612214D0
(en)
|
2016-07-14 |
2016-08-31 |
Univ Oxford Innovation Ltd |
Method
|
|
EP3487507A4
(en)
|
2016-07-21 |
2020-04-08 |
American Gene Technologies International, Inc. |
VIRAL VECTORS FOR THE TREATMENT OF PARKINSON'S DISEASE
|
|
WO2018022747A1
(en)
*
|
2016-07-26 |
2018-02-01 |
Senti Biosciences, Inc. |
Genetic erasers
|
|
JP2018029521A
(ja)
*
|
2016-08-24 |
2018-03-01 |
国立研究開発法人農業・食品産業技術総合研究機構 |
ｍｉＲ３９８標的核酸配列を含む、遺伝子導入のためのウイルスベクター
|
|
US10457940B2
(en)
|
2016-09-22 |
2019-10-29 |
University Of Massachusetts |
AAV treatment of Huntington's disease
|
|
AU2017341849B2
(en)
|
2016-10-13 |
2024-03-21 |
University Of Massachusetts |
AAV capsid designs
|
|
CA3048313A1
(en)
|
2017-01-06 |
2018-07-12 |
Stabilitech Biopharma Ltd |
Virus
|
|
CN107384868A
(zh)
*
|
2017-02-17 |
2017-11-24 |
中国农业科学院上海兽医研究所 |
永生化原代绵羊肺细胞系的构建及其应用
|
|
US11820999B2
(en)
|
2017-04-03 |
2023-11-21 |
American Gene Technologies International Inc. |
Compositions and methods for treating phenylketonuria
|
|
EP3634449A4
(en)
*
|
2017-05-08 |
2021-03-17 |
Gritstone Oncology, Inc. |
ALPHAVIRUS NEOANTIGEN VECTORS
|
|
CA3062426A1
(en)
|
2017-05-08 |
2018-11-15 |
Flagship Pioneering Innovations V, Inc. |
Compositions for facilitating membrane fusion and uses thereof
|
|
US11859179B2
(en)
|
2017-05-09 |
2024-01-02 |
University Of Massachusetts |
Methods of treating amyotrophic lateral sclerosis (ALS)
|
|
US11767539B2
(en)
|
2017-05-12 |
2023-09-26 |
University Of Massachusetts |
Viral vector production
|
|
IL270882B2
(en)
|
2017-05-24 |
2024-02-01 |
Univ Barcelona Autonoma |
Viral expression vectors containing the coding sequence for FIBROBLAST GROWTH FACTOR 21 (FGF21
|
|
JP2020524996A
(ja)
|
2017-06-16 |
2020-08-27 |
アメリカン ジーン テクノロジーズ インターナショナル インコーポレイテッド |
ヒトガンマデルタｔ細胞を介する腫瘍細胞傷害性の活性化のための方法および組成物
|
|
LT3428194T
(lt)
|
2017-07-14 |
2021-12-10 |
Immatics Biotechnologies Gmbh |
Pagerinta dvejopo savitumo polipeptido molekulė
|
|
US11612625B2
(en)
|
2017-07-26 |
2023-03-28 |
Oncorus, Inc. |
Oncolytic viral vectors and uses thereof
|
|
IT201700086403A1
(it)
|
2017-07-27 |
2019-01-27 |
Univ Del Piemonte Orientale |
Endothelial-specific promoter sequences and uses thereof
|
|
NZ762100A
(en)
|
2017-08-09 |
2025-12-19 |
Bioverativ Therapeutics Inc |
Nucleic acid molecules and uses thereof
|
|
EP3444347A1
(en)
|
2017-08-18 |
2019-02-20 |
Universität Heidelberg |
Use of anti-crispr polypeptides for specific activation of cas nucleases
|
|
CN111448321A
(zh)
|
2017-09-22 |
2020-07-24 |
马萨诸塞大学 |
Sod1双表达载体及其用途
|
|
WO2019074907A1
(en)
|
2017-10-10 |
2019-04-18 |
Nantbio, Inc. |
MODIFIED EC7 CELLS WITH LOW TOXICITY FOR VIRAL PRODUCTION LOADS
|
|
EP3717505A4
(en)
|
2017-12-01 |
2021-12-01 |
Encoded Therapeutics, Inc. |
GENENICALLY MODIFIED DNA-BINDING PROTEINS
|
|
US11208651B2
(en)
*
|
2017-12-15 |
2021-12-28 |
Medizinische Hochschule Hannover |
Compound for treatment of heart failure
|
|
EP3731850A4
(en)
|
2017-12-29 |
2021-12-01 |
Oncorus, Inc. |
ONCOLYTIC VIRUS DELIVERY OF THERAPEUTIC POLYPEPTIDES
|
|
MX2020007077A
(es)
|
2018-01-04 |
2020-10-28 |
Iconic Therapeutics Inc |
Anticuerpos anti-factor tisular, conjugados anticuerpo-farmaco y metodos relacionados.
|
|
AU2019215063B2
(en)
|
2018-02-01 |
2025-10-16 |
Bioverativ Therapeutics, Inc. |
Use of lentiviral vectors expressing Factor VIII
|
|
US10716866B2
(en)
|
2018-03-29 |
2020-07-21 |
Generoath Co., Ltd |
Pharmaceutical composition comprising AIMP2-DX2 for preventing or treating neuronal diseases and use thereof
|
|
SG11202011015QA
(en)
|
2018-05-15 |
2020-12-30 |
Flagship Pioneering Innovations V Inc |
Fusosome compositions and uses thereof
|
|
CN112955174A
(zh)
|
2018-07-09 |
2021-06-11 |
旗舰先锋创新V股份有限公司 |
融合剂脂质体组合物和其用途
|
|
EP3833766A1
(en)
|
2018-08-09 |
2021-06-16 |
Bioverativ Therapeutics Inc. |
Nucleic acid molecules and uses thereof for non-viral gene therapy
|
|
JP7450945B2
(ja)
|
2018-08-30 |
2024-03-18 |
テナヤ セラピューティクス， インコーポレイテッド |
ミオカルディンおよびａｓｃｌ１を用いた心細胞リプログラミング
|
|
EP3856762A1
(en)
|
2018-09-28 |
2021-08-04 |
Voyager Therapeutics, Inc. |
Frataxin expression constructs having engineered promoters and methods of use thereof
|
|
CA3113325A1
(en)
|
2018-10-11 |
2020-04-16 |
Eidgenossische Technische Hochschule Zurich |
A method to treat disease using a nucleic acid vector encoding a highly compact multi-input logic gate
|
|
US11352646B2
(en)
|
2018-11-05 |
2022-06-07 |
American Gene Technologies International Inc. |
Vector system for expressing regulatory RNA
|
|
US20220008557A1
(en)
*
|
2018-11-14 |
2022-01-13 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions for cns delivery
|
|
EP3880832A1
(en)
|
2018-11-14 |
2021-09-22 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions for hematopoietic stem cell delivery
|
|
AU2019378883A1
(en)
|
2018-11-14 |
2021-06-03 |
Flagship Pioneering Innovations V, Inc. |
Fusosome compositions for T cell delivery
|
|
CN113631718A
(zh)
|
2018-11-14 |
2021-11-09 |
旗舰先锋创新V股份有限公司 |
用于特定隔室货物递送的组合物和方法
|
|
WO2020117713A1
(en)
*
|
2018-12-03 |
2020-06-11 |
California Institute Of Technology |
In situ readout of dna barcodes
|
|
JP7644007B2
(ja)
|
2018-12-06 |
2025-03-11 |
バイオベラティブ セラピューティクス インコーポレイテッド |
第ｉｘ因子を発現するレンチウイルスベクターの使用
|
|
WO2020132455A1
(en)
*
|
2018-12-21 |
2020-06-25 |
The Trustees Of The University Of Pennsylvania |
Compositions for drg-specific reduction of transgene expression
|
|
JP2022516318A
(ja)
*
|
2019-01-04 |
2022-02-25 |
オンコラス， インコーポレイテッド |
カプセル化ポリヌクレオチド及び使用方法
|
|
KR102248420B1
(ko)
*
|
2019-03-15 |
2021-05-06 |
주식회사 제너로스 |
miR-142-3p의 표적 서열을 포함하는 재조합 벡터
|
|
CA3133889A1
(en)
*
|
2019-04-24 |
2020-10-29 |
The Trustees Of The University Of Pennsylvania |
Compositions useful in treatment of rett syndrome
|
|
PL3976798T3
(pl)
|
2019-05-29 |
2026-04-07 |
Encoded Therapeutics, Inc. |
Kompozycje i sposoby selektywnej regulacji genów
|
|
MX2021014525A
(es)
|
2019-05-30 |
2022-03-17 |
Gritstone Bio Inc |
Adenovirus modificados.
|
|
JP7651562B2
(ja)
|
2019-09-19 |
2025-03-26 |
ジェネトン |
Ｆｋｒｐの心毒性を軽減する遺伝子治療発現系
|
|
KR20220097891A
(ko)
|
2019-09-30 |
2022-07-08 |
바이오버라티브 테라퓨틱스 인크. |
렌티바이러스 벡터 제형
|
|
KR102461417B1
(ko)
*
|
2019-11-11 |
2022-11-01 |
주식회사 온코크로스 |
아데노바이러스 벡터를 포함하는 전립선암 진단용 조성물
|
|
WO2021184006A1
(en)
*
|
2020-03-13 |
2021-09-16 |
Duke University |
Compositions for the treatment of nash and associated disorders and methods of using same
|
|
EP4127190A4
(en)
*
|
2020-03-30 |
2024-05-29 |
Greffex, Inc. |
IMPROVING THE PRODUCTION OF ADENOVIRUS-BASED GENETIC TRANSFER VECTORS
|
|
KR20230003569A
(ko)
*
|
2020-04-27 |
2023-01-06 |
더 트러스티스 오브 더 유니버시티 오브 펜실베니아 |
Cdkl5 결핍 장애 (cdd)의 치료에 유용한 조성물
|
|
MX2022014258A
(es)
*
|
2020-05-12 |
2023-02-22 |
Univ Pennsylvania |
Composiciones para la reducción específica de un fármaco de la expresión de transgén.
|
|
US20230256117A1
(en)
|
2020-06-19 |
2023-08-17 |
Genethon |
Gene therapy expression system allowing an adequate expression in the muscles and in the heart of sgcg
|
|
MX2023000156A
(es)
|
2020-06-24 |
2023-02-16 |
Bioverativ Therapeutics Inc |
Metodos para la eliminacion de factor viii libre de preparaciones de vectores lentivirales modificados para expresar dicha proteina.
|
|
EP4179096A1
(en)
|
2020-07-10 |
2023-05-17 |
Genethon |
A novel muscle-specific promoter
|
|
CN116438308A
(zh)
|
2020-08-06 |
2023-07-14 |
磨石生物公司 |
多表位疫苗盒
|
|
WO2022046665A1
(en)
|
2020-08-23 |
2022-03-03 |
Bioverativ Therapeutics Inc. |
MODIFIED BACULOVIRUS SYSTEM FOR IMPROVED PRODUCTION OF CLOSED-ENDED DNA (ceDNA)
|
|
KR102626543B1
(ko)
*
|
2020-09-14 |
2024-01-23 |
주식회사 제너로스 |
AIMP2-DX2 및 miR-142의 표적 핵산을 포함하는 재조합 벡터
|
|
KR20220035693A
(ko)
*
|
2020-09-14 |
2022-03-22 |
주식회사 제너로스 |
표적화된 유전자 전달을 위한 아데노-부속 바이러스 벡터
|
|
JP7121086B2
(ja)
*
|
2020-09-25 |
2022-08-17 |
ウニベルシダッド アウトノマ デ バルセロナ |
脂肪組織に形質導入するのに有用なアデノ随伴ウイルスベクター
|
|
CN116406304A
(zh)
*
|
2020-09-30 |
2023-07-07 |
杰内罗蒂股份有限公司 |
使用AIMP2-DX2和任选地miR-142的靶序列及其组合物治疗年龄相关的黄斑疾病的方法
|
|
WO2022233956A1
(en)
|
2021-05-05 |
2022-11-10 |
Immatics Biotechnologies Gmbh |
Antigen binding proteins specifically binding prame
|
|
MX2023013394A
(es)
*
|
2021-05-13 |
2023-12-14 |
Akouos Inc |
Composiciones de suministro de terapia genica y metodos para tratar perdida auditiva.
|
|
MX2024002333A
(es)
|
2021-08-23 |
2024-03-07 |
Bioverativ Therapeutics Inc |
Sistema de expresion de baculovirus.
|
|
AU2022332276A1
(en)
|
2021-08-23 |
2024-04-04 |
Bioverativ Therapeutics Inc. |
Optimized factor viii genes
|
|
TW202346327A
(zh)
|
2021-09-30 |
2023-12-01 |
美商百歐維拉提夫治療公司 |
編碼具有降低免疫原性的因子ｖｉｉｉ多肽之核酸
|
|
WO2023142040A1
(en)
*
|
2022-01-29 |
2023-08-03 |
Virogin Biotech Canada Ltd. |
Transcriptional and translational dual regulated oncolytic herpes simplex virus vectors
|
|
JP2025516639A
(ja)
*
|
2022-05-13 |
2025-05-30 |
ジェネロス カンパニー， リミテッド |
ＡＩＭＰ２－ＤＸ２および必要に応じてｍｉＲ－１４２に対する標的配列を使用して網膜変性疾患を処置する方法ならびにその組成物
|
|
CN121909034A
(zh)
|
2023-07-24 |
2026-04-21 |
斯特兰德生物科技公司 |
用于产生用于体外细胞疗法的工程化免疫细胞的基于rna的合成回路
|
|
US12281311B1
(en)
|
2024-02-20 |
2025-04-22 |
Wyvern Pharmaceuticals Inc. |
Composition for regulating production of interfering ribonucleic acid
|